Paper32199764
The Myelodepletive Phenotype in Myelofibrosis: Clinical Relevance and Therapeutic Implication.
Marcellino BK and 2 others. Clin Lymphoma Myeloma Leuk, 2020. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. The Myelodepletive Phenotype in Myelofibrosis: Clinical Relevance and Therapeutic Implication. Papers, record 32199764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32199764
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Myelodepletive Phenotype in Myelofibrosis: Clinical Relevance and Therapeutic Implication.
- PubMed
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Primary Myelofibrosis | Major topic |
| Humans | |
| Phenotype |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41400273 | The hematopoietic stem cells supportive megakaryocytes as shapers of the bone marrow niche. | Eur J Histochem | 2025 | https://conductscience.org/library/papers/41400273 | PubMed |
| 41030319 | The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies. | Blood Lymphat Cancer | 2025 | https://conductscience.org/library/papers/41030319 | PubMed |
| 40643151 | Thrombocytopenia in myelofibrosis is characterized by inflammatory megakaryocytes with reduced G6B expression. | Blood | 2025 | https://conductscience.org/library/papers/40643151 | PubMed |
| 40454401 | A novel application of XPO1 inhibition for the treatment of myelofibrosis. | Blood Neoplasia | 2024 | https://conductscience.org/library/papers/40454401 | PubMed |
| 40361317 | Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40361317 | PubMed |
| 39897086 | Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real-world ERNEST-2 registry. | Hemasphere | 2025 | https://conductscience.org/library/papers/39897086 | PubMed |
| 39400386 | Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of Survival. | Eur J Haematol | 2025 | https://conductscience.org/library/papers/39400386 | PubMed |
| 39114304 | Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives. | Front Oncol | 2024 | https://conductscience.org/library/papers/39114304 | PubMed |
| 39062946 | The Variation in the Traits Ameliorated by Inhibitors of JAK1/2, TGF-β, P-Selectin, and CXCR1/CXCR2 in the Gata1low Model Suggests That Myelofibrosis Should Be Treated by These Drugs in Combination. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39062946 | PubMed |
| 38672793 | Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38672793 | PubMed |
| 38612873 | Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612873 | PubMed |
| 37894394 | A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37894394 | PubMed |
| 37835392 | Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37835392 | PubMed |
| 37747591 | Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group. | Clin Exp Med | 2023 | https://conductscience.org/library/papers/37747591 | PubMed |
| 37444441 | Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37444441 | PubMed |
| 37439808 | A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis. | Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37439808 | PubMed |
| 37243913 | The role of therapy in the outcome of patients with myelofibrosis. | Cancer | 2023 | https://conductscience.org/library/papers/37243913 | PubMed |
| 36891574 | Novel therapeutics for myelofibrosis. | Blood Res | 2023 | https://conductscience.org/library/papers/36891574 | PubMed |
| 36797153 | SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for Myelofibrosis. | Clin Lymphoma Myeloma Leuk | 2023 | https://conductscience.org/library/papers/36797153 | PubMed |
| 36485113 | New approaches to tackle cytopenic myelofibrosis. | Hematology Am Soc Hematol Educ Program | 2022 | https://conductscience.org/library/papers/36485113 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| BCR | 613 | PubTator's text mining | https://conductscience.org/library/genes/613 | NCBI Gene |
| CALR | 811 | PubTator's text mining | https://conductscience.org/library/genes/811 | NCBI Gene |
| JAK2 | 3717 | PubTator's text mining | https://conductscience.org/library/genes/3717 | NCBI Gene |
| MPL | 4352 | PubTator's text mining | https://conductscience.org/library/genes/4352 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32199764
GET https://conductscience.org/api/papers/v1/32199764/cited_by?page=2